Nodule Characterization. Subsolid Nodules.

Radiologic Clinics of North America

Volumn 52, Issue 1, 2014, Pages 47-67

  Raad, Roy A ^a   Suh, James ^b   Harari, Saul ^b   Naidich, David P ^a   Shiau, Maria ^a   Ko, Jane P ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma classification; Computed tomography; Ground glass lung nodule; Guidelines; Lung cancer; Management; Nodule characterization; Subsolid lung nodule

Indexed keywords

CANCER CLASSIFICATION; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INCIDENCE; INFLAMMATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG FIBROSIS; LUNG LOBECTOMY; LUNG NODULE; MEDICAL TERMINOLOGY; MORBIDITY; ORGANIZING PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SUBSOLID LUNG NODULE; SURVIVAL TIME; TISSUE CHARACTERIZATION; TISSUE STRUCTURE; TREATMENT INDICATION; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA CLASSIFICATION; COMPUTED TOMOGRAPHY; GROUND-GLASS LUNG NODULE; GUIDELINES; LUNG CANCER; MANAGEMENT; NODULE CHARACTERIZATION; SUBSOLID LUNG NODULE;

ADENOCARCINOMA; HUMANS; LUNG NEOPLASMS; SOLITARY PULMONARY NODULE; TERMINOLOGY AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888203410     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2013.08.011     Document Type: Review

References (145)

1. Naidich D.P., Bankier A.A., MacMahon H., et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013, 266:304-317.
2. Godoy M.C., Naidich D.P. Overview and strategic management of subsolid pulmonary nodules. JThorac Imaging 2012, 27:240-248.
3. Travis W.D., Brambilla E., Noguchi M., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. JThorac Oncol 2011, 6:244-285.
4. Hansell D.M., Bankier A.A., MacMahon H., et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008, 246:697-722.
5. Henschke C.I., Yankelevitz D.F., Mirtcheva R., et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002, 178:1053-1057.
6. Chong S., Lee K.S., Chung M.J., et al. Lung cancer screening with low-dose helical CT in Korea: experiences at the Samsung Medical Center. JKorean Med Sci 2005, 20:402-408.
7. MacRedmond R., McVey G., Lee M., et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006, 61:54-56.
8. MacRedmond R., Logan P.M., Lee M., et al. Screening for lung cancer using low dose CT scanning. Thorax 2004, 59:237-241.
9. Li F., Sone S., Abe H., et al. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 2004, 233:793-798.
10. van Klaveren R.J., Oudkerk M., Prokop M., et al. Management of lung nodules detected by volume CT scanning. NEngl J Med 2009, 361:2221-2229.
11. Felix L., Serra-Tosio G., Lantuejoul S., et al. CT characteristics of resolving ground-glass opacities in a lung cancer screening programme. Eur J Radiol 2011, 77:410-416.
12. Oh J.Y., Kwon S.Y., Yoon H.I., et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer 2007, 55:67-73.
13. Lee S.M., Park C.M., Goo J.M., et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology 2010, 255:242-251.
14. Henschke C.I., Naidich D.P., Yankelevitz D.F., et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001, 92:153-159.
15. Libby D.M., Wu N., Lee I.J., et al. CT screening for lung cancer: the value of short-term CT follow-up. Chest 2006, 129:1039-1042.
16. Khokhar S., Mironov S., Seshan V.E., et al. Antibiotic use in the management of pulmonary nodules. Chest 2010, 137:369-375.
17. Park C.M., Goo J.M., Lee H.J., et al. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics 2007, 27:391-408.
18. Gaeta M., Blandino A., Scribano E., et al. Computed tomography halo sign in pulmonary nodules: frequency and diagnostic value. JThorac Imaging 1999, 14:109-113.
19. Chung S.Y., Kim S.J., Kim T.H., et al. Computed tomography findings of pathologically confirmed pulmonary parenchymal endometriosis. JComput Assist Tomogr 2005, 29:815-818.
20. Ko J.P. Lung nodule detection and characterization with multi-slice CT. JThorac Imaging 2005, 20:196-209.
21. Kitamura H., Kameda Y., Nakamura N., et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 1996, 20:553-562.
22. Nomori H., Ohtsuka T., Naruke T., et al. Differentiating between atypical adenomatous hyperplasia and bronchioloalveolar carcinoma using the computed tomography number histogram. Ann Thorac Surg 2003, 76:867-871.
23. Kawakami S., Sone S., Takashima S., et al. Atypical adenomatous hyperplasia of the lung: correlation between high-resolution CT findings and histopathologic features. Eur Radiol 2001, 11:811-814.
24. Kodama K., Higashiyama M., Yokouchi H., et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002, 73:386-392. [discussion: 92-3].
25. Yang P.S., Lee K.S., Han J., et al. Focal organizing pneumonia: CT and pathologic findings. JKorean Med Sci 2001, 16:573-578.
26. Kim H.Y., Shim Y.M., Lee K.S., et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007, 245:267-275.
27. Kodama K., Higashiyama M., Takami K., et al. Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. Eur J Cardiothorac Surg 2008, 34:1068-1074.
28. Yoshida J., Nagai K., Yokose T., et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. JThorac Cardiovasc Surg 2005, 129:991-996.
29. Yang Z.G., Sone S., Takashima S., et al. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. AJR Am J Roentgenol 2001, 176:1399-1407.
30. Takashima S., Maruyama Y., Hasegawa M., et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol 2003, 180:817-826.
31. SEER cancer statistics review, 1975-2008. Available at:. Accessed January 30, 2012. http://seer.cancer.gov/csr/1975_2008/results_merged/sect_15_lung_bronchus.pdf.
32. Aoki T., Tomoda Y., Watanabe H., et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001, 220:803-809.
33. Noguchi M., Morikawa A., Kawasaki M., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852.
34. Travis W.D., Garg K., Franklin W.A., et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. JClin Oncol 2005, 23:3279-3287.
35. Travis W.D., Garg K., Franklin W.A., et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. JThorac Oncol 2006, 1:S13-S19.
36. Carey F.A., Wallace W.A., Fergusson R.J., et al. Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. Thorax 1992, 47:1041-1043.
37. Weng S., Tsuchiya E., Satoh Y., et al. Multiple atypical adenomatous hyperplasia of type II pneumonocytes and bronchiolo-alveolar carcinoma. Histopathology 1990, 16:101-103.
38. Nakanishi K. Alveolar epithelial hyperplasia and adenocarcinoma of the lung. Arch Pathol Lab Med 1990, 114:363-368.
39. Nakahara R., Yokose T., Nagai K., et al. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia. Thorax 2001, 56:302-305.
40. Yoshida Y., Shibata T., Kokubu A., et al. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 2005, 50:1-8.
41. Sakamoto H., Shimizu J., Horio Y., et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. JPathol 2007, 212:287-294.
42. Westra W.H., Baas I.O., Hruban R.H., et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 1996, 56:2224-2228.
43. Maeshima A.M., Tochigi N., Yoshida A., et al. Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence. JThorac Oncol 2010, 5:466-471.
44. Koga T., Hashimoto S., Sugio K., et al. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia. Am J Clin Pathol 2002, 117:464-470.
45. Yoshizawa A., Motoi N., Riely G.J., et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011, 24:653-664.
46. Sica G., Yoshizawa A., Sima C.S., et al. Agrading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010, 34:1155-1162.
47. Park C.M., Goo J.M., Kim T.J., et al. Pulmonary nodular ground-glass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions?. Chest 2008, 133:1402-1409.
48. Okita R., Yamashita M., Nakata M., et al. Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. Ann Thorac Surg 2005, 79:e1-e2.
49. Yanagawa M., Kuriyama K., Koyama M., et al. Solitary pulmonary metastases from renal cell carcinoma: comparison of high-resolution CT with pathological findings. Radiat Med 2006, 24:680-686.
50. Gaeta M., Volta S., Scribano E., et al. Air-space pattern in lung metastasis from adenocarcinoma of the GI tract. JComput Assist Tomogr 1996, 20:300-304.
51. Kang M.J., Kim M.A., Park C.M., et al. Ground-glass nodules found in two patients with malignant melanomas: different growth rate and different histology. Clin Imaging 2010, 34:396-399.
52. Gudavalli R., Diaz-Guzman E., Arrossi A.V., et al. Fleeting alveolar infiltrates and reversed halo sign in patients with breast cancer treated with tangential beam irradiation. Chest 2011, 139:454-459.
53. Drakopanagiotakis F., Paschalaki K., Abu-Hijleh M., et al. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest 2011, 139:893-900.
54. Marchiori E., Zanetti G., Hochhegger B., et al. Reversed halo sign on computed tomography: state-of-the-art review. Lung 2012, 190:389-394.
55. Georgiadou S.P., Sipsas N.V., Marom E.M., et al. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis 2011, 52:1144-1155.
56. Marchiori E., Melo S.M., Vianna F.G., et al. Pulmonary histoplasmosis presenting with the reversed halo sign on high-resolution CT scan. Chest 2011, 140:789-791.
57. Marchiori E., Zanetti G., Meirelles G.S., et al. The reversed halo sign on high-resolution CT in infectious and noninfectious pulmonary diseases. AJR Am J Roentgenol 2011, 197:W69-W75.
58. Marchiori E., Zanetti G., Escuissato D.L., et al. Reversed halo sign: high-resolution CT scan findings in 79 patients. Chest 2012, 141:1260-1266.
59. Walker C.M., Mohammed T.L., Chung J.H. "Reversed halo sign.". JThorac Imaging 2011, 26:W80.
60. Maimon N. A47-year-old female with shortness of breath and "reversed halo sign.". Eur Respir Rev 2010, 19:83-85.
61. Kim S.J., Lee K.S., Ryu Y.H., et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol 2003, 180:1251-1254.
62. Takashima S., Sone S., Li F., et al. Small solitary pulmonary nodules (< or= 1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol 2003, 180:955-964.
63. Nakajima R., Yokose T., Kakinuma R., et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. JComput Assist Tomogr 2002, 26:323-329.
64. Hara M., Oda K., Ogino H., et al. Focal fibrosis as a cause of localized ground glass attenuation (GGA)-CT andMR findings. Radiat Med 2002, 20:93-95.
65. MacMahon H., Austin J.H., Gamsu G., et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005, 237:395-400.
66. Goetti R., Winklehner A., Gordic S., et al. Automated attenuation-based kilovoltage selection: preliminary observations in patients after endovascular aneurysm repair of the abdominal aorta. AJR Am J Roentgenol 2012, 199:W380-W385.
67. Koyama H., Ohno Y., Kono A.A., et al. Effect of reconstruction algorithm on image quality and identification of ground-glass opacities and partly solid nodules on low-dose thin-section CT: experimental study using chest phantom. Eur J Radiol 2010, 74:500-507.
68. Funama Y., Awai K., Liu D., et al. Detection of nodules showing ground-glass opacity in the lungs at low-dose multidetector computed tomography: phantom and clinical study. JComput Assist Tomogr 2009, 33:49-53.
69. Willemink M.J., de Jong P.A., Leiner T., et al. Iterative reconstruction techniques for computed tomography Part 1: technical principles. Eur Radiol 2013, 23(6):1623-1631.
70. Singh S., Kalra M.K., Gilman M.D., et al. Adaptive statistical iterative reconstruction technique for radiation dose reduction in chest CT: a pilot study. Radiology 2011, 259:565-573.
71. Higuchi K., Nagao M., Matsuo Y., et al. Detection of ground-glass opacities by use of hybrid iterative reconstruction (iDose) and low-dose 256-section computed tomography: a phantom study. Radiol Phys Technol 2013, 6(2):299-304.
72. Lee H.J., Goo J.M., Lee C.H., et al. Predictive CT findings of malignancy in ground-glass nodules on thin-section chest CT: the effects on radiologist performance. Eur Radiol 2009, 19:552-560.
73. Takashima S., Sone S., Li F., et al. Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR Am J Roentgenol 2003, 180:1255-1263.
74. Takahashi S., Tanaka N., Okimoto T., et al. Long term follow-up for small pure ground-glass nodules: implications of determining an optimum follow-up period and high-resolution CT findings to predict the growth of nodules. Jpn J Radiol 2012, 30:206-217.
75. Matsuguma H., Mori K., Nakahara R., et al. Characteristics of subsolid pulmonary nodules which show growth during follow-up with computed tomography. Chest 2013, 143(2):436-443.
76. Honda T., Kondo T., Murakami S., et al. Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification. Clin Radiol 2013, 68:e21-e26.
77. Aoki T., Hanamiya M., Uramoto H., et al. Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers. Radiology 2012, 264:590-596.
78. Gaeta M., Caruso R., Blandino A., et al. Radiolucencies and cavitation in bronchioloalveolar carcinoma: CT-pathologic correlation. Eur Radiol 1999, 9:55-59.
79. Kuriyama K., Tateishi R., Doi O., et al. Prevalence of air bronchograms in small peripheral carcinomas of the lung on thin-section CT: comparison with benign tumors. AJR Am J Roentgenol 1991, 156:921-924.
80. Farooqi A.O., Cham M., Zhang L., et al. Lung cancer associated with cystic airspaces. AJR Am J Roentgenol 2012, 199:781-786.
81. Suzuki K., Kusumoto M., Watanabe S., et al. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006, 81:413-419.
82. Vazquez M., Carter D., Brambilla E., et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009, 64:148-154.
83. Suzuki K., Asamura H., Kusumoto M., et al. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002, 74:1635-1639.
84. Oda S., Awai K., Liu D., et al. Ground-glass opacities on thin-section helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia. AJR Am J Roentgenol 2008, 190:1363-1368.
85. Nakata M., Saeki H., Takata I., et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002, 121:1464-1467.
86. Ikeda N., Maeda J., Yashima K., et al. Aclinicopathological study of resected adenocarcinoma 2 cm or less in diameter. Ann Thorac Surg 2004, 78:1011-1016.
87. Sagawa M., Higashi K., Usuda K., et al. Curative wedge resection for non-invasive bronchioloalveolar carcinoma. Tohoku J Exp Med 2009, 217:133-137.
88. Higashiyama M., Kodama K., Yokouchi H., et al. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg 1999, 68:2069-2073.
89. Matsuguma H., Yokoi K., Anraku M., et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. JThorac Cardiovasc Surg 2002, 124:278-284.
90. Yanagawa M., Kuriyama K., Kunitomi Y., et al. One-dimensional quantitative evaluation of peripheral lung adenocarcinoma with or without ground-glass opacity on thin-section CT images using profile curves. Br J Radiol 2009, 82:532-540.
91. Yanagawa M., Tanaka Y., Kusumoto M., et al. Automated assessment of malignant degree of small peripheral adenocarcinomas using volumetric CT data: correlation with pathologic prognostic factors. Lung Cancer 2010, 70:286-294.
92. Ohde Y., Nagai K., Yoshida J., et al. The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma. Lung Cancer 2003, 42:303-310.
93. Ujita M., Renzoni E.A., Veeraraghavan S., et al. Organizing pneumonia: perilobular pattern at thin-section CT. Radiology 2004, 232:757-761.
94. Chen S.W., Price J. Focal organizing pneumonia mimicking small peripheral lung adenocarcinoma on CT scans. Australas Radiol 1998, 42:360-363.
95. Sumikawa H., Johkoh T., Nagareda T., et al. Pulmonary adenocarcinomas with ground-glass attenuation on thin-section CT: quantification by three-dimensional image analyzing method. Eur J Radiol 2008, 65:104-111.
96. Tateishi U., Uno H., Yonemori K., et al. Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis. Chest 2005, 128:3276-3283.
97. Nakata M., Sawada S., Yamashita M., et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. JThorac Cardiovasc Surg 2005, 129:1226-1231.
98. Kakinuma R., Kodama K., Yamada K., et al. Performance evaluation of 4 measuring methods of ground-glass opacities for predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer: a multicenter study. JComput Assist Tomogr 2008, 32:792-798.
99. Haraguchi N., Satoh H., Kikuchi N., et al. Prognostic value of tumor disappearance rate on computed tomography in advanced-stage lung adenocarcinoma. Clin Lung Cancer 2007, 8:327-330.
100. Lee H.Y., Lee K.S. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. JThorac Imaging 2011, 26:106-118.
101. Yankelevitz D.F., Gupta R., Zhao B., et al. Small pulmonary nodules: evaluation with repeat CT-preliminary experience. Radiology 1999, 212:561-566.
102. Goo J.M., Tongdee T., Tongdee R., et al. Volumetric measurement of synthetic lung nodules with multi-detector row CT: effect of various image reconstruction parameters and segmentation thresholds on measurement accuracy. Radiology 2005, 235:850-856.
103. de Hoop B., Gietema H., van de Vorst S., et al. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology 2010, 255:199-206.
104. Mull R.T. Mass estimates by computed tomography: physical density from CT numbers. AJR Am J Roentgenol 1984, 143:1101-1104.
105. Revel M.P., Bissery A., Bienvenu M., et al. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?. Radiology 2004, 231:453-458.
106. Revel M.P., Lefort C., Bissery A., et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology 2004, 231:459-466.
107. Oda S., Awai K., Murao K., et al. Computer-aided volumetry of pulmonary nodules exhibiting ground-glass opacity at MDCT. AJR Am J Roentgenol 2010, 194:398-406.
108. Ko J.P., Berman E.J., Kaur M., et al. Pulmonary nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry. Radiology 2012, 262:662-671.
109. Hiramatsu M., Inagaki T., Matsui Y., et al. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth. JThorac Oncol 2008, 3:1245-1250.
110. Hasegawa M., Sone S., Takashima S., et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000, 73:1252-1259.
111. Oda S., Awai K., Murao K., et al. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: assessment with computer-aided three-dimensional volumetry. Acad Radiol 2011, 18:63-69.
112. Chang B., Hwang J.H., Choi Y.H., et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013, 143:172-178.
113. Min J.H., Lee H.Y., Lee K.S., et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer 2010, 69:123-126.
114. Zhang L., Yankelevitz D.F., Carter D., et al. Internal growth of nonsolid lung nodules: radiologic-pathologic correlation. Radiology 2012, 263:279-286.
115. Kakinuma R., Ohmatsu H., Kaneko M., et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. JComput Assist Tomogr 2004, 28:17-23.
116. Cloran F.J., Banks K.P., Song W.S., et al. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity. Lung Cancer 2010, 68:66-71.
117. Raz D.J., Odisho A.Y., Franc B.L., et al. Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma. JThorac Cardiovasc Surg 2006, 132:1189-1195.
118. Heyneman L.E., Patz E.F. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 2002, 38:261-266.
119. Higashi K., Ueda Y., Yagishita M., et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. JNucl Med 2000, 41:85-92.
120. Lee H.Y., Lee K.S., Han J., et al. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer 2009, 65:170-175.
121. Maeda R., Isowa N., Onuma H., et al. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size. Interact Cardiovasc Thorac Surg 2009, 9:70-73.
122. Tsunezuka Y., Shimizu Y., Tanaka N., et al. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size. World J Surg 2007, 31:314-317.
123. Chun E.J., Lee H.J., Kang W.J., et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: the feasibility of integrated (18)F-FDG PET/CT. Lung Cancer 2009, 65:180-186.
124. Sawada E., Nambu A., Motosugi U., et al. Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings. Jpn J Radiol 2010, 28:251-258.
125. Sun J.S., Park K.J., Sheen S.S., et al. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers. Lung Cancer 2009, 66:205-210.
126. Kim T.J., Park C.M., Goo J.M., et al. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?. AJR Am J Roentgenol 2012, 198:83-88.
127. Erasmus J.J., Macapinlac H.A. Low-sensitivity FDG-PET studies: less common lung neoplasms. Semin Nucl Med 2012, 42:255-260.
128. Yap C.S., Schiepers C., Fishbein M.C., et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. Eur J Nucl Med Mol Imaging 2002, 29:1166-1173.
129. Okada M., Nakayama H., Okumura S., et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. JThorac Cardiovasc Surg 2011, 141:1384-1391.
130. Goudarzi B., Jacene H.A., Wahl R.L. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT. JNucl Med 2008, 49:1585-1592.
131. Godoy M.C., Naidich D.P. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009, 253:606-622.
132. Shimizu K., Ikeda N., Tsuboi M., et al. Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT. Lung Cancer 2006, 51:173-179.
133. Kim T.J., Lee J.H., Lee C.T., et al. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 2008, 190:234-239.
134. Krishna G., Gould M.K. Minimally invasive techniques for the diagnosis of peripheral pulmonary nodules. Curr Opin Pulm Med 2008, 14:282-286.
135. Lindell R.M., Hartman T.E., Swensen S.J., et al. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest 2009, 136:1586-1595.
136. Guyatt G., Gutterman D., Baumann M.H., et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006, 129:174-181.
137. Detterbeck F.C., Lewis S.Z., Diekemper R., et al. Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:7S-37S.
138. Asamura H. Minimally invasive approach to early, peripheral adenocarcinoma with ground-glass opacity appearance. Ann Thorac Surg 2008, 85:S701-S704.
139. Kohno T., Fujimori S., Kishi K., et al. Safe and effective minimally invasive approaches for small ground glass opacity. Ann Thorac Surg 2010, 89:S2114-S2117.
140. Koike T., Togashi K., Shirato T., et al. Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg 2009, 88:1106-1111.
141. Nakamura H., Kawasaki N., Taguchi M., et al. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. Br J Cancer 2005, 92:1033-1037.
142. El-Sherif A., Gooding W.E., Santos R., et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13year analysis. Ann Thorac Surg 2006, 82:408-415. [discussion: 415-6].
143. Okada M., Koike T., Higashiyama M., et al. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. JThorac Cardiovasc Surg 2006, 132:769-775.
144. Nakamura K., Saji H., Nakajima R., et al. Aphase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2010, 40:271-274.
145. Gould M.K., Donington J., Lynch W.R., et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:e93S-e120S.